Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis.

Respir Res · 2018 · PMC6194688 · PMID 30340638

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The adjusted differences in TLC showed a trend similar to that of FVC; however, the differences in DLco from baseline were significant before and after treatment.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.